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Abstract
Purpose:  To  evaluate  the  relationship  between  mean  apparent  diffusion  coefﬁcient  (ADC)  and
post-surgical  Gleason  scores.  To  determine  the  diagnostic  accuracy  of  multiparametric  magnetic
resonance  imaging  (mp-MRI)  on  a  1.5  T  magnet  in  distinguishing  low,  intermediate  and  high-
grade prostate  tumors.
Material  and  methods:  This  is  a  retrospective  institutional-review-board-approved,  single-
center study  including  30  patients  (median  age,  60  years)  who  underwent  mp-MRI  before
prostatectomy  for  prostate  cancer.  Using  histological  reports  for  guidance,  the  tumors  were
localized in  ADC  maps,  and  mean  ADCs  were  measured  and  examined  for  correlation  with
Gleason scores.  2  patients  had  2  measurable  foci,  so  a  total  of  32  tumors  were  studied.  The  diag-
nostic accuracy  of  the  mean  ADC  was  assessed  by  using  the  area  under  the  receiver  operating
characteristic  curve  (ROC).
Results:  In  the  differentiation  of  tumors  with  a  Gleason  score  of  6  from  those  with  a  Gleason
score of  at  least  7,  mean  ADC  yielded  an  AUC  of  0.76  (95%  conﬁdence  interval:  0.59,  0.93).  In
the differentiation  of  tumors  with  Gleason  scores  of  6  or  7  from  those  with  a  Gleason  score  of
at least  8,  mean  ADC  yielded  an  AUC  of  0.94  (95%  conﬁdence  interval:  0.86,  1.00).
Conclusion:  Mean  ADC  values  may  allow  a  correct  assessment  of  the  patient  risk  using  a  1.5  T
magnet without  ERC.sa  de  Urologia.  Published  by  Elsevier  Espan˜a,  S.L.U.  This  is  an  open
BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/© 2016  Associac¸a˜o  Portugue
access article  under  the  CC  
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A  utilidade  da  quantiﬁcac¸ão do  coeﬁciente  aparente  de  difusão  na  estratiﬁcac¸ão de
risco  do  cancro  da  próstata  por  ressonância  magnética  em  1,5  T  sem  sonda  endorretal
Resumo
Objetivo:  Avaliar  a  relac¸ão  entre  os  valores  de  coeﬁciente  aparente  de  difusão  (ADC)  e  os  scores
de Gleason  (SG)  pós-cirúrgicos  e  determinar  a  acuidade  diagnóstica  da  ressonância  magnética
multiparamétrica  (RM-Mp)  1.5  T  sem  sonda  endorretal  na  distinc¸ão  de  carcinomas  da  próstata
de baixo,  intermédio  e  alto  grau.
Material  e  métodos: Estudo  retrospetivo,  cientíﬁca  e  eticamente  aprovado,  incluindo  30
doentes (idade  média:  60  anos)  submetidos  a  RM-Mp  pré-prostatectomia.  Utilizando  os
relatórios histológicos  como  guia,  os  tumores  foram  localizados  nos  mapas  de  ADC,  com  vista
a quantiﬁcar  os  coeﬁcientes.  Dois  doentes  apresentaram  2  focos  mensuráveis,  pelo  que  foram
estudados 32  tumores.  A  relac¸ão  entre  os  valores  de  ADC  e  o  SG  foi  analisada  através  do  coeﬁ-
ciente de  correlac¸ão  de  Spearman.  Para  avaliar  a  acuidade  diagnóstica  dos  valores  ADC,  foram
obtidas receiver  operating  characteristic  curves  (curvas  ROC).
Resultados:  Os  valores  de  ADC  mostraram  uma  correlac¸ão  negativa  signiﬁcativa  com  o  SG.  Na
diferenciac¸ão de  tumores  com  SG  de  6  e  SG  ≥  7,  obteve-se  AUC  de  0,76  (intervalo  de  conﬁanc¸a
95%: 0,59;  0,93).  Na  diferenciac¸ão  de  tumores  com  SG  de  6  ou  7  e  SG  ≥  8,  obteve-se  AUC  de
0,94 (intervalo  de  conﬁanc¸a  95%:  0,86;  1,00).
Conclusão:  A  medic¸ão  dos  valores  de  ADC  num  aparelho  de  1,5  T  sem  sonda  endorretal  é  útil
na estratiﬁcac¸ão  de  risco  do  cancro  da  próstata.
© 2016  Associac¸a˜o  Portuguesa  de  Urologia.  Publicado  por  Elsevier  Espan˜a,  S.L.U.  Este e´  um
artigo Open  Access  sob  uma  licenc¸a  CC  BY-NC-ND  (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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tion,  staging  and  active  surveillance  purposes.  Among  thesentroduction
he  use  of  multiparametric  magnetic  resonance  imaging
mp-MRI)  has  signiﬁcantly  changed  the  diagnostic  approach
nd  management  of  prostate  cancer.  It  combines  the  con-
entional  sequences,  T1  and  T2  weighted  imaging  (WI),  with
t  least  two  functional  studies  which  may  include  diffusion
eighted  imaging  (DWI),  dynamic  contrast-enhanced  (DCE)
nd  spectroscopy.1,2
Detection,  staging,  tumor  aggressiveness  assessment,
nd  recurrence  suspicion  constitute  its  main  indications.
he  adding  of  functional  studies  improved  the  accuracy
f  MRI  and  allowed  the  analysis  of  new  parameters  like
umor  aggressiveness  that  inspires  the  use  of  mp-MRI  in
ctive  surveillance.  Both  DWI  and  spectroscopy  allow  this
ssessment,  the  ﬁrst  by  studying  the  effect  of  the  increased
ellular  density  on  free  water  motion,  and  the  second  by
nalyzing  changes  on  the  concentration  of  some  metabolites
ike  choline,  creatine  and  citrate.3--5
This  functional  imaging  technique  assesses  the  random
ovement  of  water  molecules  in  different  physical  media.
t  is  possible  through  the  application  of  diffusion-sensitizing
radients  with  distinct  strengths,  known  as  b  values  and
easured  in  seconds  per  square  millimeter  (s/mm2).  It
eans  that  with  a  b  value  of  0  s/mm2,  there  is  no  gradient
nd  the  signal  intensity  is  based  on  T2  weighting.  At  high
 values,  such  as  1000  s/mm2,  the  water  molecules  within
 highly  cellular  tissue  retain  their  high  signal  and  persist
right  on  DWI,  as  may  occur  within  a  tumor.  In  contrast,  tis-
ues  containing  water  moving  freely,  like  the  bladder,  will
ose  their  signal.6--9
DWI  allows  a  quantitative  analysis  through  the  calculus
f  the  apparent  diffusion  coefﬁcient  (ADC),  measured  in
p
r
square  millimeters  per  second.  This  quantiﬁcation  is  dis-
layed  parametrically  in  a  gray-scale  map,  where  areas
f  restricted  diffusion  appear  with  a  darker  shade  of  gray
lower  ADC  values)  and  tissues  with  freely  moving  water
how  lighter  shades  of  gray  (higher  ADC  values).  Some  stud-
es  have  shown  a signiﬁcant  negative  correlation  between
he  ADC  values  of  prostate  tumors  and  prostatectomy
pecimen  Gleason  scores.  Moreover,  ADC  values  appear  to
erform  better  than  TRUS  biopsy  Gleason  scores  in  the  asso-
iation  with  prostatectomy  Gleason  scores.  ADC  values  may
llow  a  risk  stratiﬁcation  and  correct  guidance  of  low-risk
atients  toward  active  surveillance.6,10,11
This  manuscript  will  focus  on  the  role  of  DWI  in  evaluating
umor  aggressiveness.  The  purpose  of  our  study  was  to  eval-
ate  the  relationship  between  mean  ADCs  and  post-surgical
leason  scores,  and  to  determine  the  diagnostic  accuracy  of
p-MRI  on  a  1.5  T  magnet  without  endorectal  coil  in  distin-
uishing  low,  intermediate  and  high-risk  prostate  tumors.
aterial and methods
his  is  a  retrospective  institutional-review-board-approved,
ingle-center  study.
atients
ithin  a  2-year  period  (from  January  2013  to  December
014),  198  patients  underwent  prostate  mp-MRI  for  detec-atients,  32  patients  with  biopsy-proven  cancers  underwent
adical  prostatectomy.  Two  patients  were  excluded  from  the
tudy  because  of  motion  artifacts  on  MRI.  The  remaining
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1The  utility  of  ADC  values  in  the  risk  stratiﬁcation  of  prostate
30  patients  were  included  in  the  study  (median  age,  60
years,  range  50--74).
MRI  protocol
Mp-MRI  studies  were  performed  on  a  1.5  T  body  scanner
(Magnetom  Avanto;  Siemens)  with  a  33  mT/m  maximum  gra-
dient  capability  using  an  eight  channel  pelvic  phased  array
(PPA),  without  endorectal  coil  (ERC).  Peristalsis  was  not  sup-
pressed.  In  order  to  avoid  post-biopsy  hemorrhage,  mp-MRI
was  performed  at  least  6  weeks  after  biopsy.
The  study  of  the  pelvis  included  an  axial  turbo  spin-eco
T1WI  imaging  and  an  axial  blade  T2WI  with  fat  saturation.
With  regard  to  the  prostate  gland  study,  we  performed  a  set
of  axial,  coronal  and  sagittal  high-resolution  T2WI  (3  mm;
gap  0.6  mm;  FOV  20  cm;  matrix  310  ×  320).  An  axial  DWI
with  b  values  of  0,  50,  1000  and  1200  s/mm2,  and  ADC  maps
were  automatically  generated  by  the  imager  software.  DCE-
MRI  using  an  axial  fat-saturated  3D  Vibe  T1W  MR  sequence
after  administration  of  gadoterate  meglumine,  with  a  dose
of  0.2  mmol/kg  of  body  weight  as  a  bolus  injection,  was  also
performed.
Imaging  and  histological  analysis
Two  radiologists  with  3  years  of  experience  in  interpreting
mp-MRI  worked  in  consensus  and  reviewed  all  images  on
a  workstation  (Advantage,  GE  Healthcare).  Using  histolog-
ical  reports  for  guidance,  the  tumors  were  retrospectively
localized  in  DWI  and  ADC  maps,  as  bright  and  dark  areas,
respectively.  Axial  T2WI  and  DCE  sequences  were  synchro-
nized  with  the  ones  above  for  a  better  localization  of  the
lesions  and  a  clearer  anatomic  depiction.  T1WI  were  also
reviewed  in  order  to  exclude  hemorrhage-related  artifacts.
Six  sextants  were  considered:  left  base,  right  base,  left
midgland,  right  midgland,  left  apex,  and  right  apex.  Each
sextant  was  also  divided  into  anterior,  posterior,  lateral,  and
medial  sections.  When  possible,  each  sextant  was  further
divided  into  central  and  peripheral  gland.  All  these  divisions
were  considered  and  reported  in  order  to  precisely  localize
the  tumors  and  achieve  a  better  association  with  the  histo-
logic  reports.  Only  tumors  originating  in  the  peripheral  zone
were  included  in  our  study.
Mean  ADCs  were  measured  and  examined  for  correlation
with  Gleason  scores.  The  radiologist  was  blinded  to  the  Glea-
son  scores.  All  measurements  were  performed  through  the
application  of  a  single  slice  region  of  interest  (ROI)  within
the  tumor  in  the  ADC  map,  trying  to  avoid  tumor  edges.
ROIs  had  the  same  size  for  all  tumors  (27  mm2).  In  multi-
focal  tumors,  the  two  largest  foci  were  considered  for  ADC
measurement.  In  large,  heterogeneous  tumors,  ROIs  were
placed  in  the  darkest  area  of  the  tumor.  Due  to  limitations
in  spatial  resolution,  tumors  smaller  than  5  mm  in  bigger  axis
were  not  studied.  Fig.  1  shows  an  example  of  ROI  placement.
Among  the  30  patients,  2  had  multifocal  pathology  with  vol-
ume  enough  to  measure  on  the  ADC  map,  so  a  total  of  32
tumors  were  studied.All  prostatectomies  were  performed  within  15  days  of
mp-MRI,  and  no  treatment  was  implemented  between  them.
Two  pathologists  with  5  years  of  experience  reviewed
the  specimens  and  were  blinded  to  the  MRI  results.  The
m
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rostates  were  received  fresh  from  the  operating  room,  and
oth  weight  and  dimensions  were  recorded.  All  specimens
ere  then  covered  with  two  different  color  inks  and  ﬁxed
or  24  h  in  4%  neutral  buffered  formalin.  After  ﬁxation,  the
pex  and  base  were  removed  from  each  specimen  as  thin
have  margins,  and  the  seminal  vesicles  were  amputated,
ut  into  two  halves  and  processed  in  toto.  Then  midglands
ere  sectioned  at  5  mm  intervals  perpendicular  to  the  long
xis  of  the  gland.  After  that  the  cut  specimens  were  dehy-
rated  in  graded  alcohols,  cleared  in  xylene,  embedded  in
arafﬁn,  and  examined  histologically  as  5 m-thick  whole-
ount  hematoxylin  and  eosin  (H&E)  stained  sections.  Each
lice  was  examined  for  the  presence  of  gross  and/or  micro-
copic  lesions.  Similarly  to  the  MR  analysis,  six  sextants
ere  considered:  left  base,  right  base,  left  midgland,  right
idgland,  left  apex,  and  right  apex.  Each  sextant  was  also
ivided  into  anterior,  posterior,  lateral,  and  medial  sections.
ach  tumor  was  measured  in  three  dimensions  and  a  Glea-
on  score  was  given.  When  several  foci  were  found,  Gleason
cores  were  given  separately.  In  order  to  better  locate  the
umor  and  improve  correlation  with  MRI  ﬁndings,  the  short-
st  transversal  and  longitudinal  distances  were  measured
etween  each  lesion  and  the  capsule  and  base  and/or  apex
argins,  respectively.
tatistical  analysis
wo  variables  were  considered:  ADC  values,  a  numeric  vari-
ble,  and  Gleason  scores,  an  ordinal  variable.  In  relation
o  the  Gleason  scores,  eight  different  grade  groups  were
dentiﬁed  according  to  the  primary  and  secondary  features
resent.  Gleason  score  was  discretized  into  two  new  binary
ariables  (score  6  vs  score  higher  than  6;  scores  6,  7  vs
cores  8,  9).  An  exploratory  analysis  was  carried  out  for
ll  variables.  Continuous  variables  were  presented  as  mean
r  median,  standard  deviation  (SD)  or  inter-quartile  range
25th  percentile--75th  percentile),  as  required.
The  relationship  between  ADCs  and  ordinal  Gleason  score
roups  was  ﬁrstly  analyzed  by  applying  Spearman’s  correla-
ion  coefﬁcient.  Data  was  also  displayed  in  a  scatterplot.
oreover,  in  order  to  study  the  diagnostic  accuracy  of  the
ean  ADC,  logistic  regression  models  were  ﬁtted  to  the
ata  considering  the  two  previous  deﬁned  binary  variables
s  the  outcome.  Predictive  and  discriminative  abilities  of
he  models  were  assessed  by  the  Hosmer--Lemeshow  good-
ess  of  ﬁt  test  and  by  the  area  under  the  receiver  operating
haracteristic  curve  (ROC),  respectively.  A  model  with  good
t  will  have  a lower  observed  Hosmer--Lemeshow  chi-square
tatistic  value  and  a  non-signiﬁcant  p-value.  A  level  of  sig-
iﬁcance  ˛  =  0.05  was  considered.  Statistical  analyses  were
erformed  with  software  (SPSS,  version  22.0.01).
esults
0  patients  were  included  in  the  study,  and  a  total  of
2  tumors  were  considered  to  ADC  measurement.  12  (37.5%),
3  (40.7%),  and  7  (21.4%)  had  Gleason  scores  of  6,  7,  and
ore  than  or  equal  to  8,  respectively.
Mean  ADC  showed  a  signiﬁcant  negative  correlation  with
leason  ordinal  scores.  The  Spearman  p  value  for  mean  ADC
as  −0.594  (p  <  0.001).  According  to  the  scatterplot,  some
84  J.L.  Dias  et  al.
1 min/max: 366/558
A B
1 mean/SD: 443.2/65.5
1 area: 0.17 sq.cm
1 pixel: 5
Figure  1  Example  of  ROI  placement.  Left  peripheral  prostate  cancer  in  a  67-year-old  man  (PSA  9.5  ng/mL;  Gleason  Score  of  8).
(A) Axial  T2-weighted  MR  image  shows  a  left  peripheral  hypointense  tumor  (arrow).  (B)  ADC  map  reveals  left  suspicious  hyposignal
lesion and  ROI  placement  (arrow).
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Figure  2  Scatterplot:  relationship  between  Gleason  scores
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an  important  role  in  non-invasive  aggressiveness  assess-
ment  and,  when  combined  with  serum  PSA,  may  be  able  tond mean  ADC.
verlap  is  found  between  the  ADCs  measured  in  tumors  with
leason  scores  of  6  and  7  (Fig.  2).
In  the  differentiation  of  tumors  with  a  Gleason  score  of
 from  those  with  a  Gleason  score  of  at  least  7,  mean  ADC
ielded  an  AUC  of  0.76  (95%  conﬁdence  interval:  0.59,  0.93)
Fig.  3).  The  p  value  of  Hosmer--Lemeshow  test  was  0.789.
or  an  ADC  of  0.906  ×  10−3 mm2/s,  sensitivity  and  speci-
city  were  83.3%  (95%  conﬁdence  interval:  51.6%,  97.9%)
nd  70.0%  (95%  conﬁdence  interval:  45.7%,  88.1%),  respec-
ively.
In  the  differentiation  of  tumors  with  Gleason  scores  of  6
r  7  from  those  with  a  Gleason  score  of  at  least  8,  mean  ADC
ielded  an  AUC  of  0.94  (95%  conﬁdence  interval:  0.86,  1.00)
Fig.  3).  The  p  value  of  Hosmer--Lemeshow  test  was  0.965.
or  an  ADC  of  0.649  ×  10−3 mm2/s,  sensitivity  and  speciﬁcity
ere  88.0%  (95%  conﬁdence  interval:  68.8%,  97.5%)  and  100%
95%  conﬁdence  interval:  59.0%,  100%),  respectively.
a
fiscussion
his  study  shows  a  signiﬁcant  negative  correlation  between
DC  values  and  Gleason  scores,  which  is  consistent  with
ther  studies  like  those  of  Bittencourt  et  al.6 or  Verma
t  al.12 This  manuscript  also  shows  that  mp-MRI  on  a  1.5-T
agnet  without  ERC  allows  a  good  discrimination  between
leason  scores  of  6  and  more  than  6,  and  an  excellent
iscrimination  between  Gleason  scores  of  7  or  lower  and
ore  than  7.  We  were  able  to  provide  cut  offs  with  good
ensitivity  and  speciﬁcity  levels  between  different  Gleason
cores,  which  may  constitute  an  indirect  way  of  determin-
ng  biologic  aggressiveness  of  the  tumor,  with  consequent
reatment  implications.  However,  it  remains  unclear  how  to
se  ADC  quantiﬁcation  across  imaging  platforms  and  institu-
ions  since  some  deviations  have  been  shown,  with  greater
ariation  reported  at  1.5-T.  These  variations  are  probably
ultifactorial  and  depend  on  gradient  systems,  coil  systems,
ulse  sequence  design,  imaging  parameters,  susceptibility
rtifacts,  and  postprocessing.  Furthermore,  when  compar-
ng  3.0-T  and  1.5-T  magnets,  slightly  higher  values  have  been
btained  at  the  former.13--15 By  now,  the  authors  believe  that
t  is  not  possible  to  get  a  reliable  cut-off  ADC  value  for
alignancy  that  may  be  used  across  different  systems.  ADC
alues  should  then  be  obtained  and  compared  across  dif-
erent  examinations  using  the  same  protocol  and  magnet,
hich  may  be  particularly  useful  in  set  of  active  surveil-
ance.
Patients  with  Gleason  scores  of  6  are  stratiﬁed  as  low  risk
atients.  Depending  on  clinical  and  laboratorial  ﬁndings,  a
rotocol  of  active  surveillance  may  be  performed.  Serum
SA  (which  should  be  less  than  10)  is  the  most  important
aboratorial  feature,  but  PSA  velocity  and  PSA  density  may
lso  be  considered.  Since  the  randomized  biopsy  tends  to
nderestimate  the  Gleason  score,  mp-MRI  seems  to  haveccurately  estimate  the  risk.  Many  centers  consider  other
eatures  like  the  percentage  or  number  of  positive  scores
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Figure  3  ROC  curves  of  mean  ADC  in  the  differentiation  of  tumors  with  Gleason  score  of  6  from  those  with  Gleason  score  of  at
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wleast 7  and  tumors  with  Gleason  score  of  6  and  7  from  those  wi
to  estimate  tumor  volume  and  select  patients  for  active
surveillance.16,17 New  studies  should  be  developed  in  order
to  evaluate  if  mp-MRI  ﬁndings  better  estimates  tumor  vol-
ume  than  these  biopsy  features.
According  to  our  results,  mp-MRI  is  able  to  exclude
high-risk  patients,  which  are  those  with  Gleason  scores
of  at  least  8.  However,  the  distinction  between  low  and
intermediate  risk  was  not  so  good  (sensitivity  of  83%).  This
difference  was  already  expected  since  an  overlap  between
ADCs  on  Gleason  scores  of  6  and  7  had  been  apparent.  As
a  result,  it  seems  not  to  be  possible  to  obviate  a  guided
biopsy  whenever  ADC  values  decrease.  A  decrease  on  ADC
is  probably  related  to  an  increase  in  the  histological  aggres-
siveness  and  should  be  considered  as  tumor  progression.
Other  features  should  obviously  be  evaluated,  like  the  size,
the  existence  of  new  foci,  changes  on  post-gadolinium
dynamic  patterns,  and  signs  of  extra-prostatic  extension.
It  is  not  possible  for  all  institutions  to  acquire  the  most
recent  technology  and  accompany  the  evolution  on  proto-
cols,  so  each  department  should  adapt  technical  parameters
according  to  the  magnet  and  software  characteristics,  and
evaluate  its  own  diagnostic  accuracy.  In  the  particular  set
of  ADC  measurements,  the  results  should  be  compared  with
those  derived  from  similar  MR  systems  and  protocols.13,14
According  to  some  authors,  optimal  mp-MRI  on  a  1.5  T  mag-
net  requires  the  use  of  an  endorectal  coil  (ERC)  combined
with  a  pelvic  phased-array  coil  (PPA)  in  order  to  produce
high  signal  to  noise  ratios  (SNR)  and  therefore  improve  the
image  resolution  and  acquisition  speed.  However,  there  is
no  consensus  about  this  item  and  others  suggest  that  the
use  of  ERC  might  not  be  mandatory  for  tumor  detection
and  localization.  It  may  consequently  save  time  and  costs,
c
a
a
Eeason  score  of  at  least  8.
nd  cause  the  patient  less  discomfort.2,18--21 Our  results  are
oncordant  with  the  most  recent  studies  with  and  without
RC.  Therefore,  we  conclude  that  mp-MRI  on  a  1.5-T  mag-
et  without  ERC  is  highly  speciﬁc  and  sensible,  and  may  be
sed  for  assessment  of  tumor  aggressiveness.
Our  study  had  some  limitations.  First,  it  was  retrospec-
ive.  Second,  our  results  may  not  apply  to  a  large  patient
opulation,  because  we  have  only  considered  patients  who
nderwent  radical  prostatectomy  and  only  7  patients
21.4%)  had  a  Gleason  score  of  8  or  higher.  Third,  these
esults  may  only  apply  to  peripheral  tumors.  Considering
entral  and  transitional  tumors  show  distinct  behavior  on
WI,  a  speciﬁc  study  should  be  performed.  Fourth,  our  ADCs
ere  derived  from  single  slice-based  ROIs.  Moreover,  only
 ROI  was  placed  within  each  tumor  foci  (in  the  darkest
rea).  So,  we  performed  a  visual,  qualitative  evaluation,
nd  did  not  quantitatively  study  the  entire  foci.  Fifth,  the
lice  thicknesses  of  prostatectomy  step-sections  and  ADC
aps  were  not  exactly  the  same.
Overall,  our  study  shows  results  similar  to  other
anuscripts.  Nevertheless,  it  is  important  to  emphasize
hat  limitations  in  acquiring  the  most  recent  technology
hould  not  constraint  protocol  evolution  and  adaptation
y  each  institution.  Sustained  analysis  with  internal  tech-
ology  should  be  performed  in  order  to  assess  diagnostic
ccuracy  and  validate  technical  protocols.  In  summary,  our
esults  show  that  mean  ADC  values  are  inversely  correlated
ith  prostatectomy  Gleason  scores  of  peripheral  tumors.  In
ombination  with  PSA  levels,  mean  ADC  values  may  allow
 correct  assessment  of  the  patient  risk  for  treatment  and
ctive  surveillance  purposes,  on  a  1.5  T  magnet  without
RC.
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